Inventor
GISSMANN LUTZ
DE21 patents
⚠️ This page may combine multiple inventors who share the name “GISSMANN LUTZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV LOYOLA CHICAGO
6 patentsUS6228368B1May 8, 2001
Papilloma virus capsomere formulations and method of use
UNIV LOYOLA CHICAGO65 citations96
US6599508B1Jul 29, 2003
Papilloma virus-like particles, fusion proteins as well as processes for their production
UNIV LOYOLA CHICAGO39 citations95
US6066324AMay 23, 2000
Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles
UNIV LOYOLA CHICAGO50 citations95
US7754430B2Jul 13, 2010
Papilloma virus capsomere vaccine formulations and methods of use
UNIV LOYOLA CHICAGO9 citations84
US7371391B2May 13, 2008
Papilloma virus capsomere vaccine formulations and methods of use
UNIV LOYOLA CHICAGO4 citations74
US7416732B2Aug 26, 2008
Papilloma virus-like particles, fusion proteins as well as processes for their production
UNIV LOYOLA CHICAGO1 citations62
BEHRINGWERKE AG
4 patentsUS5629161AMay 13, 1997
Use of HVP-16 E6 and E7-gene derived peptides to diagnose HPV-16-associated invasive cervical cancer
BEHRINGWERKE AG68 citations96
US5547846AAug 20, 1996
Immunogenic regions on the E7 protein of human papillomavirus type 16
BEHRINGWERKE AG32 citations91
US5601973AFeb 11, 1997
Seroreactive regions on HPV 16 proteins E1 and E2
BEHRINGWERKE AG7 citations74
US5665533ASep 9, 1997
Skin test to human papillomavirus type 16
BEHRINGWERKE AG9 citations65
DADE BEHRING MARBURG GMBH
4 patentsUS6531127B2Mar 11, 2003
Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2
DADE BEHRING MARBURG GMBH18 citations92
US6322794B1Nov 27, 2001
Seroreactive epitopes on proteins of human papillomavirus (HPV) 18
DADE BEHRING MARBURG GMBH17 citations82
US6221577B1Apr 24, 2001
Seroreactive regions on HPV 16-proteins E1 and E2
DADE BEHRING MARBURG GMBH2 citations63
US6723317B2Apr 20, 2004
Antibodies specific for seroreactive regions on HPV 16 protein E1
DADE BEHRING MARBURG GMBH0 citations52
DEUTSCHES KREBSFORSCH
3 patentsUS10731228B2Aug 4, 2020
Diagnostic transcript and splice patterns of HR-HPV in different cervical lesions
DEUTSCHES KREBSFORSCH0 citations47
US7354714B2Apr 8, 2008
Production and applications for polyvalent vaccines against diseases caused by papilloma viruses
DEUTSCHES KREBSFORSCH0 citations47
US7320861B2Jan 22, 2008
Polyvalent vaccine against diseases caused by papilloma viruses, method for the production and the use thereof
DEUTSCHES KREBSFORSCH0 citations47